Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 6139-6142, December 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, M.
Right arrow Articles by Katsunuma, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, M.
Right arrow Articles by Katsunuma, T.

Inhibition of Human DNA Polymerase {alpha} by {alpha}1-Antichymotrypsin1

Michio Tsuda, Masashi Masuyama and Tsunehiko Katsunuma

Department of Biochemistry, School of Medicine, Tokai University, Bohseidai, Isehara, Kanagawa, 259-11, Japan

{alpha}1-Antichymotrypsin (ACT), which is known as an efficient serum protease inhibitor and is detected in tumor cell nuclei, was found to inhibit the activity of DNA polymerase {alpha} purified from human stomach adenocarcinoma. The concentration of ACT required for 50% inhibition was 1.0 mg/ml and the manner of its inhibition showed the partially competitive relationship between ACT and DNA in the assay system. Furthermore the removal of ACT by anti-ACT antibody lost its antichymotryptic and anti-DNA polymerase activities in parallel. On the other hand, it did not inhibit the activity of human DNA polymerase ß. Other human serum proteins including serum albumin, {alpha}1-acid glycoprotein, {alpha}1-antitrypsin, and immunoglobulin G as well as other protease inhibitors such as leupeptin, pepstatin, phenylmethylsulfonyl fluoride, and chymostatin did not affect the activity of DNA polymerase {alpha}. Furthermore ACT heated at 60°C did not inhibit DNA polymerase {alpha}, although it could still bind to DNA as well as native ACT. It was therefore concluded that the inhibitory action of ACT on DNA polymerase {alpha} was a direct phenomenon unrelated to its protease inhibitory or DNA binding activities.

1 This work was supported in part by a Tokai Medical Research Grant and a grant from Yamanouchi Foundation for Research on Metabolic Disorders.

Received 10/21/85. Revised 4/23/86. Revised 6/24/86. Accepted 8/21/86.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Naidoo, B. S. Cooperman, Z.-m. Wang, X.-z. Liu, and H. Rubin
Identification of Lysines within [IMAGE]1-Antichymotrypsin Important for DNA Binding
J. Biol. Chem., June 16, 1995; 270(24): 14548 - 14555.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.